Skip to content

Colorectal EMR and ESD on continuous use of anticoagulants.

Colorectal EMR and ESD on continuous use of anticoagulants. - Colorectal EMR and ESD on continuous use of anticoagulants.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018655
Enrollment
50
Registered
2015-08-12
Start date
2015-03-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Patinets taking anticoagulants because of thrombotic risk (CHADS2 score more than 2 or mechnical valve replacement) 2. Colorectal polyps more than 5mm in diameter 3. Within 3 polyps can be resected in one procedure 4. Over 20 years old 5. PS(ECOG)0, 1, 2 6. patients without severe anemia, moderate to severe thrombocytopenia, severe liver dysfunction and severe renal dysfunction

Interventions

anticoagulant therapy

Sponsors

Division of Gastroenterology Teikyo University Chiba Medical Center
Lead Sponsor
Shin-Tokyo Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with anticoagulant therapy (CHADS2 score ). Colorectal polyps more than 5mm in diameter. Patients without severe anemia, moderate to severe thrombocytopenia, severe liver dysfunction and severe renal dysfunction. PS(ECOG) 0, 1, 2

Exclusion criteria

Exclusion criteria: Patients taking antithrombotic agents other than warfarin or NOAC. Patients taking NSAIDs and not able to interrupt 7 days before endoscopic therapy and 28 days after therapy. Female who are pregnant or lactating. Patients who have psychiatric disease. patients who have active bacterial infection or fungal infection. Patients with poor control hypertension(SBP more than 160mmHg or DBP more than 100mmHg). Patients with chronic lung disease who need continuous oxygen therapy.

Design outcomes

Primary

MeasureTime frame
Lower gastrointestinal hemorrhage after endoscopic resetion

Secondary

MeasureTime frame
Hemorrhage not related with endoscopic therapy, thrombotic complications, perforation, other complications.

Countries

Japan

Contacts

Public ContactShigetaka Tounou

Teikyo University Chiba Medical Center Division of Gastroenterology

s-tounou@med.teikyo-u.ac.jp0436-62-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026